Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Investigation of mechanisms underlying NK cell-mediated protection from HIV disease progression

EF 2009-10

Résumé
Human immunodeficiency virus type-1 (HIV-1) is the cause of acquired immunodeficiency syndrome (AIDS) and is one of the 3 major infectious disease killers globally. Some people appear to be resistant to HIV infection, remaining uninfected despite exposure. Of those who become infected a small subset of about 5% progress slowly without treatment. There is epidemiological evidence that Natural Killer (NK) cells play a role in HIV resistance as well as slow disease progression in infected subjects. The anti-viral activity of NK cells depends on interactions between certain NK receptors (KIR3DL1) and the targets or ligands for these receptors (HLA-Bw4) present on cells that HIV can infect. There are numerous variants of KIR3DL1 and HLA-Bw4 that interact with different potencies. The strength of the KIR/HLA interaction can be further modified by the presence of small fragments of HIV. The ideal combination(s) of KIR3DL1 and HLA-Bw4 for protection against HIV infection are unknown. In this project we will work with cells from individuals with identified KIR3DL1 and HLA-Bw4 variants. We will study the linkage between the anti-viral function of NK cells from individuals having KIR/HLA receptor ligand pairs that are associated, or not, with favorable outcomes following exposure to HIV. The aim of this project will be to identify the roles of KIR3DL1, HLA-Bw4 and HIV fragments in enhancing the anti-viral activities of NK cells. Results generated in this project will contribute to improving our understanding of the role of NK cells in protection from HIV observed in HIV resistant subjects and/or slow disease progressors. Such information would be relevant to vaccine design by providing a rationale for manipulating NK activity at the time of vaccination to favor the development of immunity that is effective at preventing or treating HIV infection.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
197145
Name
Parsons Matthew S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Investigation of mechanisms underlying NK cell-mediated protection from HIV disease progression
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Aqcuired Immune Deficiency Syndrome; Human Immunodeficiency Virus; Human Leukocyte Antigen; Killer Immunoglobulin-Like Receptors; Natural Killer Cells
Abstract
Human immunodeficiency virus type-1 (HIV-1) is the cause of acquired immunodeficiency syndrome (AIDS) and is one of the 3 major infectious disease killers globally. Some people appear to be resistant to HIV infection, remaining uninfected despite exposure. Of those who become infected a small subset of about 5% progress slowly without treatment. There is epidemiological evidence that Natural Killer (NK) cells play a role in HIV resistance as well as slow disease progression in infected subjects. The anti-viral activity of NK cells depends on interactions between certain NK receptors (KIR3DL1) and the targets or ligands for these receptors (HLA-Bw4) present on cells that HIV can infect. There are numerous variants of KIR3DL1 and HLA-Bw4 that interact with different potencies. The strength of the KIR/HLA interaction can be further modified by the presence of small fragments of HIV. The ideal combination(s) of KIR3DL1 and HLA-Bw4 for protection against HIV infection are unknown. In this project we will work with cells from individuals with identified KIR3DL1 and HLA-Bw4 variants. We will study the linkage between the anti-viral function of NK cells from individuals having KIR/HLA receptor ligand pairs that are associated, or not, with favorable outcomes following exposure to HIV. The aim of this project will be to identify the roles of KIR3DL1, HLA-Bw4 and HIV fragments in enhancing the anti-viral activities of NK cells. Results generated in this project will contribute to improving our understanding of the role of NK cells in protection from HIV observed in HIV resistant subjects and/or slow disease progressors. Such information would be relevant to vaccine design by providing a rationale for manipulating NK activity at the time of vaccination to favor the development of immunity that is effective at preventing or treating HIV infection.
Competitiondate
200911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Parsons, Matthew S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~